MediciNova $44M Financing To Advance Products To Phase II Sep. 7, 2004 As it prepares to move three products into Phase II studies, MediciNova Inc. raised $44 million in a Series C round. (BioWorld Today)Read More
Holiday Notice Sep. 7, 2004 BioWorld Today's offices are closed Monday, Sept. 6, in observance of Labor Day. No issue will be published. Read More
RSS